Literature DB >> 25818191

Neuroprotection against 6-OHDA-induced oxidative stress and apoptosis in SH-SY5Y cells by 5,7-Dihydroxychromone: Activation of the Nrf2/ARE pathway.

Dong-Woo Kim1, Kyoung-Tae Lee2, Jaeyoung Kwon3, Hak Ju Lee2, Dongho Lee4, Woongchon Mar5.   

Abstract

AIMS: The aim of this study was to prove the neuroprotective effect of 5,7-Dihydroxychromone (DHC) through the Nrf2/ARE signaling pathway. To elucidate the mechanism, we investigated whether 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in SH-SY5Y cells could be attenuated by DHC via activating the Nrf2/ARE signal and whether DHC could down-regulate 6-OHDA-induced excessive ROS generation MAIN
METHODS: To evaluate the neuroprotective effect of DHC against 6-OHDA-induced apoptosis, FACS analysis was performed using PI staining. The inhibitory effect of DHC against 6-OHDA-induced ROS generation was evaluated by DCFH-DA staining assay. Additionally, translocation of Nrf2 to the nucleus and increased Nrf2/ARE binding activity, which subsequently resulted in the up-regulation of the Nrf2-dependent antioxidant gene expressions including HO-1, NQO1, and GCLc, were evaluated by Western blotting and EMSA. KEY
FINDINGS: Pre-treatment of DHC, one of the constituents of Cudrania tricuspidata, significantly protects 6-OHDA-induced neuronal cell death and ROS generation. Also, DHC inhibited the expression of activated caspase-3 and caspase-9 and cleaved PARP in 6-OHDA-induced SH-SY5Y cells. DHC induced the translocation of Nrf2 to the nucleus and increased Nrf2/ARE binding activity which results in the up-regulation of the expression of Nrf2-dependent antioxidant genes, including HO-1, NQO1, and GCLc. The addition of Nrf2 siRNA abolished the neuroprotective effect of DHC against 6-OHDA-induced neurotoxicity and the expression of Nrf2-mediated antioxidant genes. SIGNIFICANCE: Activation of Nrf2/ARE signal by DHC exerted neuroprotective effects against 6-OHDA-induced oxidative stress and apoptosis. This finding will give an insight that activating Nrf2/ARE signal could be a new potential therapeutic strategy for neurodegenerative disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  5,7-Dihydroxychromone; 6-OHDA; Cudrania tricuspidata; Neuroprotection; Nrf2/ARE pathway; Oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 25818191     DOI: 10.1016/j.lfs.2015.02.026

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Inorganic Arsenic Induces NRF2-Regulated Antioxidant Defenses in Both Cerebral Cortex and Hippocampus in Vivo.

Authors:  Yang Zhang; Xiaoxu Duan; Jinlong Li; Shuo Zhao; Wei Li; Lu Zhao; Wei Li; Huifang Nie; Guifang Sun; Bing Li
Journal:  Neurochem Res       Date:  2016-05-10       Impact factor: 3.996

2.  Duloxetine Protects Human Neuroblastoma Cells from Oxidative Stress-Induced Cell Death Through Akt/Nrf-2/HO-1 Pathway.

Authors:  Daiane Fátima Engel; Jade de Oliveira; Vicente Lieberknecht; Ana Lucia Severo Rodrigues; Andreza Fabro de Bem; Nelson Horácio Gabilan
Journal:  Neurochem Res       Date:  2017-11-13       Impact factor: 3.996

3.  Loss of NQO1 generates genotoxic estrogen-DNA adducts in Fuchs Endothelial Corneal Dystrophy.

Authors:  Taiga Miyajima; Geetha Melangath; Shan Zhu; Neha Deshpande; Shivakumar Vasanth; Bodhisattwa Mondal; Varun Kumar; Yuming Chen; Marianne O Price; Francis W Price; Eleanor G Rogan; Muhammad Zahid; Ula V Jurkunas
Journal:  Free Radic Biol Med       Date:  2019-12-17       Impact factor: 7.376

4.  Natural Approaches for Neurological Disorders-The Neuroprotective Potential of Codium tomentosum.

Authors:  Joana Silva; Alice Martins; Celso Alves; Susete Pinteus; Helena Gaspar; Amparo Alfonso; Rui Pedrosa
Journal:  Molecules       Date:  2020-11-23       Impact factor: 4.411

5.  Carnosine suppresses neuronal cell death and inflammation induced by 6-hydroxydopamine in an in vitro model of Parkinson's disease.

Authors:  Maho Kubota; Nahoko Kobayashi; Toshifumi Sugizaki; Mikako Shimoda; Masahiro Kawahara; Ken-Ichiro Tanaka
Journal:  PLoS One       Date:  2020-10-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.